The risk of urinary retention‐related AEs was higher in males, patients ≥ 65 years old, patients with prostate volume ≥ 50 mL, patients with BPH, and patients using α1 blockers or PDE5 inhibitors. The gene discussed is PDE5A; the disease is benign prostatic hyperplasia.